DK50497A - Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider - Google Patents

Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider Download PDF

Info

Publication number
DK50497A
DK50497A DK050497A DK50497A DK50497A DK 50497 A DK50497 A DK 50497A DK 050497 A DK050497 A DK 050497A DK 50497 A DK50497 A DK 50497A DK 50497 A DK50497 A DK 50497A
Authority
DK
Denmark
Prior art keywords
polypeptides
reacts
factor viii
those
react
Prior art date
Application number
DK050497A
Other languages
English (en)
Inventor
Theodore S Zimmerman
Carol A Fulcher
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK50497(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK50497A publication Critical patent/DK50497A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK050497A 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider DK50497A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US55650883A 1983-11-30 1983-11-30

Publications (1)

Publication Number Publication Date
DK50497A true DK50497A (da) 1997-05-02

Family

ID=27046849

Family Applications (2)

Application Number Title Priority Date Filing Date
DK174984A DK172036B1 (da) 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf
DK050497A DK50497A (da) 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK174984A DK172036B1 (da) 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf

Country Status (12)

Country Link
EP (3) EP0123945B2 (da)
JP (2) JPH0829089B2 (da)
AT (2) ATE135400T1 (da)
AU (1) AU572128B2 (da)
CA (1) CA1341506C (da)
DE (2) DE3486423T3 (da)
DK (2) DK172036B1 (da)
FI (1) FI841281A7 (da)
IE (2) IE80858B1 (da)
NO (1) NO167533C (da)
SG (2) SG48229A1 (da)
ZA (1) ZA842418B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
DE3586402T3 (de) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Proteinzusammensetzung mit Koagulations-wirkung und Verfahren zu ihrer Herstellung.
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
JPH0764879B2 (ja) * 1984-01-12 1995-07-12 チロン コ−ポレイシヨン フアクタ−ｖ▲ｉｉｉ▼ｃに対するモノクロ−ナル抗体
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
AU607927B2 (en) * 1986-06-24 1991-03-21 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0690126B1 (en) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
CA2634663C (en) 1999-02-22 2009-08-25 University Of Connecticut Novel albumin-free factor viii formulations
EP1418810A4 (en) 2001-08-03 2006-08-02 Us Gov Health & Human Serv TREATMENT OF HEMOPHILIA ORAL
EP2385825B1 (en) 2008-11-07 2018-10-10 University of Connecticut Factor viii formulations
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
CN120028415A (zh) * 2025-03-19 2025-05-23 山西溯源生物科技有限公司 一种高密度脂蛋白亚分型检测方法、检测试剂盒及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
DE3486423T3 (de) 2001-02-08
ATE135400T1 (de) 1996-03-15
NO841277L (no) 1984-10-01
DE3486423T2 (de) 1996-09-19
IE80858B1 (en) 1999-04-21
ATE155490T1 (de) 1997-08-15
SG49675A1 (en) 1998-06-15
DK174984A (da) 1984-10-01
EP0123945B2 (en) 2000-04-19
EP0123945B1 (en) 1996-03-13
JPS59184130A (ja) 1984-10-19
DE3486423D1 (de) 1996-04-18
EP0770396A2 (en) 1997-05-02
DE3486453T2 (de) 1998-02-26
DE3486453D1 (de) 1997-08-21
CA1341506C (en) 2006-06-06
NO167533B (no) 1991-08-05
EP0123945A1 (en) 1984-11-07
EP0561427A1 (en) 1993-09-22
IE80638B1 (en) 1998-10-21
IE840788L (en) 1984-09-30
JPH0638790A (ja) 1994-02-15
FI841281L (fi) 1984-10-01
EP0561427B1 (en) 1997-07-16
FI841281A7 (fi) 1984-10-01
IE960783L (en) 1984-09-30
NO167533C (no) 1991-11-13
SG48229A1 (en) 1998-04-17
ZA842418B (en) 1984-11-28
DK172036B1 (da) 1997-09-22
AU572128B2 (en) 1988-05-05
EP0770396A3 (en) 1997-07-23
JPH0829089B2 (ja) 1996-03-27
FI841281A0 (fi) 1984-03-30
AU2627284A (en) 1984-10-04
DK174984D0 (da) 1984-03-30

Similar Documents

Publication Publication Date Title
NO841277L (no) Nye faktor viii koagulerende polypeptider, og monoklonale antistoffer overfor disse
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
FR2715664B1 (fr) Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
MY8600514A (en) Monoclonal-antibody-producing hybird cell line, antibody and method of preparing it, therepeutic composition containing it and its diagnostic and therapeutic uses
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0212403A3 (en) Monoclonal antibodies to mucin-like human differentiation antigens
LU90528I2 (fr) Immunoglobulines humanises leurs production et utilisation
DE3382495D1 (de) Protein-a material und dessen herstellung.
DK113389A (da) Monoklonale antistoffer
DE59309458D1 (de) Synthetische Peptide, Antikörper dagegen und ihre Verwendung
JPS56103115A (en) Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human t cell antigen
DE3650032D1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
ES8505409A1 (es) Procedimiento para purificar interferon de humano
ATE58172T1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
KR870004137A (ko) 항인간 인터로이킨 1항체(Anti Hunam Interleukin 1 Antibody)와 그의 제법 및 그의 사용법
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
ATE221122T1 (de) Monoklonale antikörper, verfahren zu ihrer herstellung sowie ihre verwendung
ATE62709T1 (de) Monoklonale antikoerper.
EP0328248A3 (en) Monoclonal antibodies against a follicle-stimulating hormone
EP0287012A3 (en) Anti-r-binder monoclonal antibody, process for preparing the same and application of the same
RU2000103038A (ru) Специфичные анкроду моноклональные антитела, фрагменты антител, их смеси или производные
EP0089771A3 (en) Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan
EP0349258A3 (en) Method of determining the differentiation of a human t-cell
ATE34408T1 (de) Interleukin-2-aktivitaethemmender hybridomaantik¯rper und seine verwendung als reagenz zur bestimmung von interleukin-2, herstellung dieses antikoerpers, verfahren zur herstellung von hybridzellen, die anti-interleukin-2-antikoerper produzieren, und die so erhaltenen zellen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment